Iteos Therapeutics earnings were -$121.3M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest ITOS earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$45.4M, up 536.3% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, ITOS reported annual earnings of -$112.6M, with -216.5% growth. The next ITOS earnings date is Mar 4, 2025.
What were Iteos Therapeutics's earnings last quarter?
On ITOS's earnings call on Invalid Date, Iteos Therapeutics (NASDAQ: ITOS) reported Q3 2024 earnings per share (EPS) of -$1.05, up 16.67% year over year. Total ITOS earnings for the quarter were -$45.36 million. In the same quarter last year, Iteos Therapeutics's earnings per share (EPS) was -$0.90.
The next ITOS earnings date is Invalid Date. Add ITOS to your watchlist to be reminded of Iteos Therapeutics's next earnings date.
What was ITOS's earnings growth in the past year?
As of Iteos Therapeutics's earnings date in Invalid Date, Iteos Therapeutics's earnings has grown year over year. ITOS earnings in the past year totalled -$121.25 million.
Is Iteos Therapeutics profitable or losing money?
As of the last Iteos Therapeutics earnings report, Iteos Therapeutics is currently losing money. Iteos Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$121.25 million, a 96.71% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.